BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9708473)

  • 21. Cilnidipine as an agent to lower blood pressure without sympathetic nervous activation as demonstrated by iodine-123 metaiodobenzylguanidine imaging in rat hearts.
    Sakaki T; Naruse H; Masai M; Takahashi K; Ohyanagi M; Iwasaki T; Fukuchi M
    Ann Nucl Med; 2003 Jun; 17(4):321-6. PubMed ID: 12932117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria.
    Piñol C; Cobos A; Cases A; Esmatges E; Soler J; Closas J; Pascual R; Planas J
    Kidney Int Suppl; 1996 Jun; 55():S85-7. PubMed ID: 8743519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac sympathetic nervous system in early essential hypertension assessed by 123I-MIBG.
    Sakata K; Shirotani M; Yoshida H; Kurata C
    J Nucl Med; 1999 Jan; 40(1):6-11. PubMed ID: 9935049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure.
    Takeishi Y; Atsumi H; Fujiwara S; Takahashi K; Tomoike H
    J Nucl Med; 1997 Jul; 38(7):1085-9. PubMed ID: 9225795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
    Staessen JA; Fagard R; Thijs L; Celis H; Arabidze GG; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Dollery CT; Fletcher AE; Forette F; Leonetti G; Nachev C; O'Brien ET; Rosenfeld J; Rodicio JL; Tuomilehto J; Zanchetti A
    Lancet; 1997 Sep; 350(9080):757-64. PubMed ID: 9297994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure.
    Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    Heart; 2006 May; 92(5):625-30. PubMed ID: 16159967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fixed-dose combination enalapril/nitrendipine: a review of its use in mild-to-moderate hypertension.
    Siddiqui MA; Plosker GL
    Drugs; 2004; 64(10):1135-48. PubMed ID: 15139792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enalapril in experimental hypertension and acute heart failure: comparison with calcium channel blockers.
    Sweet CS; Ludden CT; Adkins E; Seymour AA; Emmert S; Ribeiro LG
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S15-9. PubMed ID: 2422487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension.
    Gerritsen TA; Bak AA; Stolk RP; Jonker JJ; Grobbee DE
    J Hypertens; 1998 May; 16(5):689-96. PubMed ID: 9797181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of isradipine and enalapril effects on regional carotid circulation in patients with hypertension with unilateral internal carotid artery stenosis.
    Akopov SE; Simonian NA
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):562-70. PubMed ID: 9388037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure.
    Ligtenberg G; Blankestijn PJ; Oey PL; Klein IH; Dijkhorst-Oei LT; Boomsma F; Wieneke GH; van Huffelen AC; Koomans HA
    N Engl J Med; 1999 Apr; 340(17):1321-8. PubMed ID: 10219067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ambulatory continuous 24-hour blood pressure monitoring in the diagnosis and therapy of arterial hypertension and modification by the antihypertensive agents enalapril, metoprolol, mepindolol and nitrendipine].
    Schrader J; Schoel G; Buhr-Schinner H; Warneke G; Kandt M; Haupt A; Scheler F
    Klin Wochenschr; 1988 Sep; 66(18):928-39. PubMed ID: 2846947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension.
    Staessen JA; Thijs L; Fagard RH; Birkenhäger WH; Arabidze G; Babeanu S; Gil-Extremera B; Bulpitt CJ; Davidson C; de Leeuw PW; Efstratopoulos AD; Fletcher AE; Fogari R; Jääskivi M; Kawecka-Jaszcz K; Nachev C; Petrie JC; Seux ML; Tuomilehto J; Webster J; Yodfat Y
    Hypertension; 1998 Sep; 32(3):410-6. PubMed ID: 9740604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes.
    Mosconi L; Ruggenenti P; Perna A; Mecca G; Remuzzi G
    Kidney Int Suppl; 1996 Jun; 55():S91-3. PubMed ID: 8743521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension.
    Rump LC
    Arzneimittelforschung; 2010; 60(3):124-30. PubMed ID: 20422943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the antihypertensive efficiency of nitrendipine, metoprolol, mepindolol and enalapril using ambulatory 24-hour blood pressure monitoring.
    Schrader J; Schoel G; Buhr-Schinner H; Kandt M; Warneke G; Armstrong VW; Scheler F
    Am J Cardiol; 1990 Oct; 66(12):967-72. PubMed ID: 2220621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resetting baroreceptors to a lower arterial pressure level by enalapril avoids baroreflex mediated activation of sympathetic nervous system by nifedipine.
    Zhang W; Wang Z
    Life Sci; 2001 May; 68(25):2769-79. PubMed ID: 11432443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.